-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Sign up for news updates
National Lung Screening Trial
-
Balancing the Benefits and Harms of Lung Cancer Screening
In the National Lung Screening Trial, screening with 2 years of annual low-dose computed tomography (LDCT) achieved a 20% decrease in lung cancer mortality in high-risk populations when compared with chest radiography. A decade later, in March 2021, the U.S. Preventive Services Task Force (USPSTF) expanded the eligibility for U.S. adults to ages 50 to…
-
On the Backs of Specialists: LDCT Screening Has Heightened the Importance of Recent Improvements in Surgical and Radiation Techniques
By Brendon Stiles, MD, and Drew Moghanaki, MD, MPH Posted: June 24, 2020 Annual low-dose computed tomography (LDCT) detects more early-stage lung cancers and saves lives by preventing death in people who develop lung cancer. The recent report on the long-term follow-up of patients in the National Lung Screening Trial (NLST) makes a powerful argument…
-
Disparities in Meeting Eligibility Criteria for Lung Cancer Screening
By Kim L. Sandler, MD, Melinda C. Aldrich, MPH, PhD, and Jeffrey D. Blume, PhD Posted: April 16, 2020 IN REFERENCE TO: Aldrich MC, Mercaldo SF, Sandler KL, Blot WJ, Grogan EL, Blume JD. Evaluation of USPSTF Lung Cancer Screening Guidelines Among African American Adult Smokers. JAMA Oncol. 2019 Jun 27. [Epub ahead of print].…
-
A Cloud-Based Computerized System for the Korean Lung Cancer Screening Project
By Jin Mo Goo, MD, PhD, and Yeol Kim, MD, MPH, PhD Posted: April 16, 2020 Dr. Jin Mo Goo Dr. Yeol Kim In 2015, based on the evidence from the National Lung Screening Trial, the Korean multisociety collaborative committee developed and published a…
-
Smoking Cessation Prior to Lung Cancer Surgery
By Jessica Donington, MD, MSCR Posted: November 12, 2019 Dr. Jessica Donington Approximately 80% to 85% of patients undergoing lung cancer resections have a smoking history, and 20% are active smokers. Never smokers have improved short- and long-term outcomes following lung resection compared to those who have smoked. The value of smoking cessation prior to or…
View ILCN Archives
Provider Resources
Popular Articles